Stocks
Vanda Pharmaceuticals (VNDA) EBITDA margin US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EBITDA margin, % | ? | 16.8% | 3.56% | -5.68% | -16.4% | -58.6% | -65.8% | |
| Changes by years, y/y, % | +3pp | -13pp | -9pp | -11pp | -42pp | |||
Vanda Pharmaceuticals. EBITDA margin, %
Vanda Pharmaceuticals. EBITDA margin, changes, pp
Vanda Pharmaceuticals (VNDA) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q2 | LTM ? | |||
| EBITDA margin, % | ? | -46.8% | -56.2% | -86.8% | -130.4% | -125.2% | -65.8% | |
| Changes by years, y/y, % | -28pp | -41pp | -25pp | -68pp | -63pp | |||
| Changes by quarters, q/q, % | +16pp | -9pp | -31pp | -44pp | +5pp | |||
